ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

May 31, 2014

Study Completion Date

November 30, 2014

Conditions
Breast Cancer
Interventions
DRUG

docetaxel

35 mg/m2 intravenously on days 1, 8, and 15 every 28 days

DRUG

cyclophosphamide

600 mg/m2 intravenously days 1, 8 every 28 days

DRUG

methotrexate

40 mg/m2 intravenously days 1 and 8 every 28 days

DRUG

5-fluorouracil

600 mg/m2 intravenously days 1 and 8 every 28 days

Trial Locations (8)

80131

Azienda Ospedaliera Cardarelli, Napoli

Istituto Nazionale dei Tumori, Divisione di Oncologia Medica C, Napoli

Unknown

Azienda Sanitaria S. Giuseppe Moscati, Monteforte Irpino

Azienda Ospedaliera G. Rummo, Benevento

Policlinico Monteluce, Sant'Andrea Delle Frate

Università Federico II, Cattedra di Oncologia Medica, Napoli

Az. Osp. Treviglio - Caravaggio, Treviglio

Ospedale S. Luca ASL SA 3, Vallo della Lucania

All Listed Sponsors
lead

National Cancer Institute, Naples

OTHER

NCT00331097 - ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment | Biotech Hunter | Biotech Hunter